Suppr超能文献

Ⅱ相酶和转运蛋白在无效循环中的相互作用:多药耐药相关蛋白 2 介导的雌二醇 17β-D-葡糖苷酸及其 3-硫酸盐代谢物的排泄对 TR(-)和 Wistar 大鼠肝灌流制剂净硫酸化的影响。

Interplay of phase II enzymes and transporters in futile cycling: influence of multidrug resistance-associated protein 2-mediated excretion of estradiol 17beta-D-glucuronide and its 3-sulfate metabolite on net sulfation in perfused TR(-) and Wistar rat liver preparations.

机构信息

Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S3M2 Canada.

出版信息

Drug Metab Dispos. 2010 May;38(5):769-80. doi: 10.1124/dmd.109.029959. Epub 2010 Feb 2.

Abstract

The hepatic disposition of estradiol 17beta-D-glucuronide (E(2)17G), a substrate of the organic anion-transporting polypeptides Oatp1a1, Oatp1a4, and Oatp1b2, was investigated in Wistar and TR(-) [multidrug resistance-associated protein (Mrp) 2-mutant] rats to elucidate how absence of Mrp2, the major excretory transporter for both E(2)17G and its 3-sulfate metabolite (E(2)3S17G), affected the net sulfation. With absence of Mrp2, lower microsomal desulfation activity and higher Mrp3 but unchanged immunoreactive protein expression of other transporters (Oatps and Mrp4) and estrogen sulfotransferase were found in TR(-) rats. In recirculating, perfused liver preparations, the rapid decay of E(2)17G and sluggish appearance of low levels of E(2)3S17G in perfusate for Wistar livers were replaced by a protracted, biexponential decay of E(2)17G and greater accumulation of E(2)3S17G, whose levels reached plateaus upon the almost complete obliteration of biliary excretion of E(2)17G and E(2)3S17G in the TR(-) liver. Much higher amounts of E(2)17G (28x) and E(2)3S17G (11x) in liver and reduced net sulfation (40 +/- 6 from 77 +/- 6% dose, P < 0.05) were observed at 2 h for the TR(-) versus the Wistar rats. With use of a physiologically based pharmacokinetic model, analytical solutions for the areas under the curve for the precursor and metabolite were obtained to reveal how enzyme- and transporter-mediated processes affected the hepatic disposition of the precursor and metabolite in futile cycling. The analytical solutions were useful to explain transporter-enzyme interplay in futile cycling and predicted that a shutdown of Mrp2 function led to decreased net sulfation of E(2)17G by raising the intracellular concentration of the metabolite, E(2)3S17G, which readily refurnished E(2)17G via desulfation.

摘要

研究了雌激素 17β-D-葡糖苷酸(E(2)17G)在 Wistar 和 TR(-)[多药耐药相关蛋白(Mrp)2 突变体]大鼠中的肝处置,以阐明缺乏 Mrp2(E(2)17G 和其 3-硫酸盐代谢物(E(2)3S17G)的主要排泄转运体)如何影响净硫酸化。在 TR(-)大鼠中,发现缺乏 Mrp2 时,微粒体去硫酸化活性降低,Mrp3 增加,但其他转运体(Oatps 和 Mrp4)和雌激素硫酸转移酶的免疫反应性蛋白表达不变。在再循环灌注肝制剂中,Wistar 肝脏灌流液中 E(2)17G 快速衰减和低水平 E(2)3S17G 出现缓慢,被 E(2)17G 的延长双指数衰减和 E(2)3S17G 的更大积累所取代,E(2)17G 和 E(2)3S17G 的胆汁排泄几乎完全阻断后,E(2)3S17G 的水平达到平台。在 TR(-)大鼠中,肝脏中 E(2)17G(28 倍)和 E(2)3S17G(11 倍)的含量更高,并且净硫酸化减少(40 +/- 6 来自 77 +/- 6%剂量,P < 0.05),在 2 小时时,与 Wistar 大鼠相比。使用基于生理学的药代动力学模型,获得了前体和代谢物曲线下面积的分析解,以揭示酶和转运体介导的过程如何影响前体和代谢物在无效循环中的肝处置。分析解有助于解释无效循环中的转运体-酶相互作用,并预测 Mrp2 功能的关闭会通过提高易通过去硫酸化重新补给 E(2)17G 的代谢物 E(2)3S17G 的细胞内浓度,从而导致 E(2)17G 的净硫酸化减少。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验